The Traderszone Network

Published in TZ Latest News 23 July, 2014 by The TZ Newswire Staff

Gilead Stock’s Great Expectations and Giant Opportunity

Gilead Sciences raked in a massive $3.48 billion from its wonder drug Sovaldi, trouncing Q2 consensus estimates. So why did this stock drop?.

read more